JCI - Citations to On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

Citations to this article

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

M Lantz, … , E Nilsson, I Olsson

M Lantz, … , E Nilsson, I Olsson

Published December 1, 1991
Citation Information: J Clin Invest. 1991;88(6):2026-2031. https://doi.org/10.1172/JCI115530.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2018	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1988	Total
Citations:	1	1	1	2	2	4	4	8	1	5	3	5	1	4	1	4	7	3	6	10	5	7	6	6	7	4	1	109

Citation information

Citations to this article (111)

Title and authors	Publication	Year
Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization. Li M, Xue Y, Chi L, Jin L	Current protein & peptide science	2024
Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection I Kang, MY Chang, TN Wight, CW Frevert	Journal of Histochemistry & Cytochemistry	2018
Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use P Chiodelli, A Bugatti, C Urbinati, M Rusnati	Molecules (Basel, Switzerland)	2015
Efficacy of Low Molecular Weight Heparin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Ventilatory Support Y Qian, H Xie, R Tian, K Yu, R Wang	COPD	2014
Heparin-derived supersulfated disaccharide inhibits allergic airway responses in sheep T Ahmed, G Smith, WM Abraham	Pulmonary Pharmacology & Therapeutics	2014
Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure S Byun, YL Sinskey, YC Lu, EH Frank, AJ Grodzinsky	Archives of Biochemistry and Biophysics	2013
Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana P Agbenorku, S Fugar, J Akpaloo, PE Hoyte-Williams, Z Alhassan, F Agyei	International Journal of Burns and Trauma	2013
Microbial heparin/heparan sulphate lyases: potential and applications CK Tripathi, J Banga, V Mishra	Applied Microbiology and Biotechnology	2012
Effect of oral and intravenous heparin tetrasaccharide on allergic airway responses: Critical role of N-sulfation T Ahmed, G Smith, WM Abraham	Pulmonary Pharmacology & Therapeutics	2012
Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study JJ Hofstra, AP Vlaar, DJ Prins, G Koh, M Levi, MJ Schultz, JM Binnekade, NP Juffermans	BMC Pulmonary Medicine	2012
The efficacy of recombinant human activated protein C (rhAPC) vs antithrombin III (at III) vs heparin, in the healing process of partial-thickness burns: a comparative study O Kritikos, M Tsagarakis, D Tsoutsos, C Kittas, V Gorgoulis, A Papalois, A Giannopoulos, G Kakiopoulos, O Papadopoulos	Annals of Burns and Fire Disasters	2012
Molecular functions of syndecan-1 in disease YH Teng, RS Aquino, PW Park	Matrix Biology	2011
Protein-Losing Enteropathy FA Sylvester	Pediatric Gastrointestinal and Liver Disease	2011
Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice R Ding, D Zhao, R Guo, Z Zhang, X Ma	Thrombosis Research	2011
Pediatric Gastrointestinal and Liver Disease FA Sylvester	Pediatric Gastrointestinal and Liver Disease	2011
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Anticoagulants, Antiplatelets, and Thrombolytics SA Mousa		2010
Cytokines in Blood from Septic Patients Interact With Surface-Immobilized Heparin J Axelsson, M Ferreira, L Adolfsson, K McCrea, R Ward, O Larm	ASAIO Journal	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock K Hayashida, Y Chen, AH Bartlett, PW Park	The Journal of biological chemistry	2008
Nadroparine Blunts Lipopolysaccharide-Induced Hypothermia and Behavioral Depression in Mice C Akyol, E Özis, A Çakmak, ES Akarsu, MA Kuzu	Journal of Investigative Surgery	2008
Series in Maternal-Fetal Medicine BE Metzger	Textbook of Diabetes and Pregnancy	2008
Fundamental and Clinical Cardiology Series PD Stein	Cardiovascular Disease in the Elderly	2008
Early intravenous unfractionated heparin and mortality in septic shock* R Zarychanski, S Doucette, D Fergusson, D Roberts, DS Houston, S Sharma, H Gulati, A Kumar	Critical Care Medicine	2008
Heparan Sulfate and Syndecan-1 are Essential in Maintaining Intestinal Epithelial Barrier Function Lars Bode, Camilla Salvestrini, Pyong Woo Park, Jin-Ping Li, Jeffrey D. Esko, Simon Murch, Hudson H. Freeze	Journal of Clinical Investigation	2007
Heparin Reduced Mortality and Sepsis in Severely Burned Children GJ Zayas, AM Bonilla, MJ Saliba	Annals of Burns and Fire Disasters	2007
Comprehensive Glycoscience S Kelm, R Ravindran	Comprehensive Glycoscience	2007
Extracellular Angiogenic Growth Factor Interactions: An Angiogenesis Interactome Survey M Rusnati, M Presta	Endothelium : journal of endothelial cell research	2006
Applied glycoproteomics—approaches to study genetic-environmental collisions causing protein-losing enteropathy L Bode, HH Freeze	Biochimica et Biophysica Acta (BBA) - General Subjects	2006
Thrombophilia and Recurrent Pregnancy Loss HJ Carp	Obstetrics and Gynecology Clinics of North America	2006
Heparan Sulfate Plays a Central Role in a Dynamic in Vitro Model of Protein-losing Enteropathy L Bode, S Murch, HH Freeze	The Journal of biological chemistry	2006
Serglycin Is the Major Secreted Proteoglycan in Macrophages and Has a Role in the Regulation of Macrophage Tumor Necrosis Factor-α Secretion in Response to Lipopolysaccharide L Zernichow, M Åbrink, J Hallgren, M Grujic, G Pejler, SO Kolset	The Journal of biological chemistry	2006
Heparan sulfate depletion amplifies TNF-α-induced protein leakage in an in vitro model of protein-losing enteropathy L Bode, EA Eklund, S Murch, HH Freeze	AJP Gastrointestinal and Liver Physiology	2005
Linear basic peptides for targeting interferon-��-glycosaminoglycan interactions: synthesis and inhibitory properties R Fernandez-Botran, P Romanovskis, X Sun, AF Spatola	The Journal of Peptide Research	2004
Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes Sheng-Li Ji, Hui-Fei Cui, Feng Shi, Yan-Qing Chi, Ji-Chao Cao, Mei-Yu Geng, Hua-Shi Guan	World journal of gastroenterology : WJG	2004
Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats Marek Dobosz, Lucjanna Mionskowska, Stanislaw Hac, Sebastian Dobrowolski, Dariusz Dymecki, Zdzislaw Wajda	World journal of gastroenterology : WJG	2004
Cytokines in recurrent miscarriage H Carp	Lupus	2004
Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity BM Brooks, AL Thomas, JW Coleman	Clinical & Experimental Immunology	2003
Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model ER Schiffer, G Reber, P Moerloose, DR Morel	Critical Care Medicine	2002
Adsorption of Inflammatory Cytokines Using a Heparin-Coated Extracorporeal Circuit M Fujita, M Ishihara, K Ono, H Hattori, A Kurita, M Shimizu, A Mitsumaru, D Segawa, K Hinokiyama, Y Kusama, M Kikuchi, T Maehara	Artificial Organs	2002
Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia W Visser, I Beckmann, MA Knook, HC Wallenburg	Acta Obstetricia et Gynecologica Scandinavica	2002
Increasedin VitroCytotoxicity of TNF-α Analog LK-805 Is Based on the Interaction with Cell Surface Heparan Sulfate Proteoglycan V Menart, I Fonda, M Kenig, VG Porekar	Annals of the New York Academy of Sciences	2002
Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats I Dotan, R Hershkoviz, F Karmeli, E Brazowski, Y Peled, D Rachmilewitz, Z Halpern	Alimentary Pharmacology & Therapeutics	2001
Inability of plasma high-density lipoproteins to inhibit cell adhesion molecule expression in human coronary artery endothelial cells A Stannard	Atherosclerosis	2001
Heparin in the treatment of burns: a review M Saliba	Burns	2001
Overexpression of EXTL3/EXTR1 enhances NF-κB activity induced by TNF-α K Mizuno, S Irie, TA Sato	Cellular Signalling	2001
Chronisch entzündliche Darmerkrankungen J Stein, A Dignass		2001
Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in Mice RN Moore, B Echtenacher, K Weigl, N Lehn, DN Männel	Infection and immunity	2001
Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial I Dotan, A Hallak, N Arber, M Santo, A Alexandrowitz, Y Knaani, R Hershkoviz, E Brazowski, Z Halpern	Digestive Diseases and Sciences	2001
Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease A Papa, S Danese, A Gasbarrini, G Gasbarrini	Alimentary Pharmacology & Therapeutics	2000
Detection of membrane-bound tumor necrosis factor (TNF): An analysis of TNF-specific reagents J Gerspach, A G�tz, G Zimmermann, C Kolle, H B�ttinger, M Grell	Microscopy Research and Technique	2000
Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides T Ahmed, J Ungo, M Zhou, C Campo	Journal of applied physiology	2000
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease C Folwaczny, B Wiebecke, K Loeschke	The American Journal of Gastroenterology	1999
Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis A Fracasso, B Baggio, E Ossi, DD Prete, L Bonfante, G Bazzato, G Gambaro	American Journal of Kidney Diseases	1999
BINDING OF INTERFERON γ BY GLYCOSAMINOGLYCANS: A STRATEGY FOR LOCALIZATION AND/OR INHIBITION OF ITS ACTIVITY R Fernandez-Botran	Cytokine	1999
Soluble Cytokine Receptors: Basic Immunology and Clinical Applications R Fernandez-Botran	Critical Reviews in Clinical Laboratory Sciences	1999
Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses C Campo, JF Molinari, J Ungo, T Ahmed	Journal of applied physiology	1999
Dexamethasone Differentially Regulates Cytokine Transcription and Translation in Macrophages Responding to Bacteria or Okadaic Acid K Gewert, U Svensson, K Andersson, E Holst, R Sundler	Cellular Signalling	1999
Endothelial Cell Contact Potentiates Release of Soluble Tumor Necrosis Factor (TNF) Receptors from the Monocyte-like Cell Line THP-1 F Björnberg, M Lantz	Journal of Interferon & Cytokine Research	1998
The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat Fries, Pagiaro, Canova, Carraro, Gasparini, Pomerri, Martin, Carlotto, Mazzon, Sturniolo, Longo	Alimentary Pharmacology & Therapeutics	1998
Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease M Noguchi, N Hiwatashi, Z Liu, T Toyota	Gut	1998
Age-dependent levels of select immunological mediators in sera of healthy children U Sack, U Burkhardt, M Borte, H Schädlich, K Berg, F Emmrich	Clinical and diagnostic laboratory immunology	1998
Histamine Content and Secretion in Basophils and Mast Cells AM Dvorak	Progress in Histochemistry and Cytochemistry	1998
Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model A Salas, M Sans, A Soriano, JC Reverter, DC Anderson, JM Piqué, J Panés	Shock	1998
Adherence to Endothelial Cells Induces Release of Soluble Tumor Necrosis Factor (TNF) Receptor Forms from Neutrophil Granulocytes F Björnberg, M Lantz	Biochemical and Biophysical Research Communications	1998
Critical Care Nephrology C Ronco, R Bellomo		1998
Effect of heparin on dextran sulfate sodium-induced colitis J R Korzenik, A Hsu, M E Robert	Digestive Diseases and Sciences	1998
Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation MS Douglas, S Ali, DA Rix, JG Zhang, JA Kirby	Immunology	1997
Growth Factors and Cytokines in Health and Disease P Martin, J McCluskey, P Mallucci, S Nodder	Growth Factors and Cytokines in Health and Disease	1997
Endothelial Cells and Extracellular Calmodulin Inhibit Monocyte Tumor Necrosis Factor Release and Augment Neutrophil Elastase Release DS Houston, CW Carson, CT Esmon	The Journal of biological chemistry	1997
Catecholamines increase monocyte TNF receptors and inhibit TNF through β 2 -adrenoreceptor activation X Guirao, A Kumar, J Katz, M Smith, E Lin, C Keogh, SE Calvano, SF Lowry	American journal of physiology. Endocrinology and metabolism	1997
Soluble TNFα Receptors Are Increased in Chronic Renal Insufficiency and Hemodialysis and Inhibit Neutrophil Priming by TNFα RA Ward, KR McLeish	Artificial Organs	1996
Importance of receptor-mediated endocytosis in peptide delivery and targeting: kinetic aspects H Sato, Y Sugiyama, A Tsuji, I Horikoshi	Advanced Drug Delivery Reviews	1996
An investigation of the effects of heparin, low molecular weight heparin, protamine, and fentanyl on the balance of pro- and anti-inflammatory cytokines in in-vitro monocyte cultures WT McBRIDE, M Armstrong, TJ McMURRAY	Anaesthesia	1996
Azotemia, TNFα, and LPS prime the human neutrophil oxidative burst by distinct mechanisms KR McLeish, JB Klein, ED Lederer, KZ Head, RA Ward	Kidney International	1996
Anticoagulation strategies for continuous renal replacement therapies: What works? RL Mehta	American Journal of Kidney Diseases	1996
Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes NA Sheikh, HN Caro, J Taverne, JH Playfair, TW Rademacher	Immunology	1996
Acute Meningococcaemia: Recent Advances in Management (with Particular Reference to Children) NJ Kennedy, AW Duncan	ANAESTH INTENS CARE	1996
Immune modulation of cardiac function: A new frontier S Sasayama	Journal of Cardiac Failure	1995
Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia H Redl, G Schlag, GR Adolf, B Natmessnig, J Davies	Infection and immunity	1995
CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice I Akhtar, JP Gold, LY Pan, JL Ferrara, XD Yang, JI Kim, KN Tan	Journal of Experimental Medicine	1995
Monocyte-related cytokines in acute myocardial infarction H Tashiro, H Shimokawa, K Yamamoto, M Nagano, M Momohara, K Muramatu, A Takeshita	American Heart Journal	1995
Nutrition Support Affects the Distribution and Organ Uptake of Cachectin/ Tumor Necrosis Factor in Rats ME Keith, KH Norwich, KN Jeejeebhoy	JPEN. Journal of parenteral and enteral nutrition	1995
Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody J Jansen, T van der Poll, M Levi, H ten Cate, H Gallati, JW ten Cate, SJ van Deventer	Journal of Clinical Immunology	1995
Low-dose heparin: a novel approach in immunosuppression A Górski, J Makula, M Morzycka-Michalik, M Lao, L Gradowska	Transplant International	1994
Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD D Zemel, AL Imholz, DR de Waart, C Dinkla, DG Struijk, RT Krediet	Kidney International	1994
Cuprophane But Not Synthetic Membrane Induces Increases in Serum Tumor Necrosis Factor-Alpha Levels During Hemodialysis E Canivet, S Lavaud, T Wong, M Guenounou, JC Willemin, G Potron, J Chanard	American Journal of Kidney Diseases	1994
Functional Interactions of Fibronectin and TNFα: A Paradigm of Physiological Linkage Between Cytokines and Extracellular Matrix Moieties L Cahalon, R Hershkoviz, D Gilat, A Miller, SK Akiyama, KM Yamada, O Lider	Cell Communication and Adhesion	1994
Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity A Schmitt-Grff, A Desmoulire, G Gabbiani, A Schmitt-Grff, A Desmoulire	Virchows Archiv	1994
The cytokine network I Olsson	Journal of Internal Medicine	1993
Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity WC Sternbergh, RG Makhoul, B Adelman	Journal of Vascular Surgery	1993
Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion R Simpson, R Alon, L Kobzik, CR Valeri, D Shepro, HB Hechtman	Annals of Surgery	1993
Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8 LM Webb, MU Ehrengruber, I Clark-Lewis, M Baggiolini, A Rot	Proceedings of the National Academy of Sciences	1993
Optimization of the L-M cell bioassay for quantitating tumor necrosis factor α in serum and plasma FE Nargi, TJ Yang	Journal of Immunological Methods	1993
Lipoprotein lipase binding to adipocytes: evidence for the presence of a heparin-sensitive binding protein A Sasaki, P Sivaram, IJ Goldberg	American journal of physiology. Endocrinology and metabolism	1993
Identification of novel heparin-releasable proteins, as well as the cytokines midkine and pleiotrophin, in human postheparin plasma WF Novotny, T Maffi, RL Mehta, PG Milner	Arteriosclerosis Thrombosis and Vascular Biology	1993
TNF-specific deactivation of granulocytes in vivo: A possible mechanism of self-protection B Schleiffenbaum, L Olgiati, J Fehr	European Journal of Haematology	1992
IBD: A vascular disorder? the case for heparin therapy JR Korzenik	Inflammatory Bowel Diseases
Angiogenesis: new aspects relating to its initiation and control K Norrby	APMIS	1997
Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients BJ Pereira, L Shapiro, AJ King, ME Falagas, JA Strom, CA Dinarello	Kidney International	1994
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays B Sallerfors, T Olofsson	European Journal of Haematology	1992
Serum levels of interleukin-6 are not dependent on the kidney function L Nässberger	Mediators of Inflammation	1992
The role of cytokines and their inhibitors in arthritis JM Dayer, H Fenner	Baillière's Clinical Rheumatology	1992
IBD: A Vascular Disorder? The Case for Heparin Therapy: JR Korzenik	Inflammatory Bowel Diseases
Low molecular weight heparin prevents the pulmonary hemodynamic and pathomorphologic effects of endotoxin in a porcine acute lung injury model A Salas, M Sans, A Soriano, JC Reverter, DC Anderson, JM Piqué, J Panés	Shock	1998
The Molecular and Cellular Biology of Wound Repair RA Clark, PM Henson		1988

Advertisement